These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Novel methodological approaches to the evaluation of the immune status in sickly children with ENT organ pathology]. Dzhamalutdinov IuA; Davudov KhSh; Saidov MZ; Nazhmudinov II; Matela II Vestn Otorinolaringol; 2009; (1):40-4. PubMed ID: 19365363 [TBL] [Abstract][Full Text] [Related]
3. [Interface between dentistry and otorhinolaryngology]. Timmenga NM; van Weissenbruch R; Raghoebar GM; Vissink A Ned Tijdschr Tandheelkd; 2000 Sep; 107(9):362-7. PubMed ID: 11383030 [TBL] [Abstract][Full Text] [Related]
4. [Bioresonance. Main principles of bioresonance and electromagnetic therapy]. Korkmazov MIu Vestn Otorinolaringol; 2008; (2):59-61. PubMed ID: 18454081 [TBL] [Abstract][Full Text] [Related]
5. [Clinical experience with Ibunac in the field of otorhinolaryngology]. Kashiwado T Jibiinkoka; 1968 Nov; 40(11):943-6. PubMed ID: 5752436 [No Abstract] [Full Text] [Related]
6. [Therapy with aerosols in infants and small children at the otorhinolaryngology departments]. Bláhová O; Picková M Z Laryngol Rhinol Otol; 1968 Aug; 47(8):620-6. PubMed ID: 5726721 [No Abstract] [Full Text] [Related]
7. [Effects of immunotropic therapy on the structure of system-forming indices in patients with urgent surgical pathology]. Sarap PV; Vinnik IuS; Ostanin AA Vestn Khir Im I I Grek; 2012; 171(4):39-43. PubMed ID: 23038912 [TBL] [Abstract][Full Text] [Related]
8. [Cytokines and their role in diagnosis and treatment of some ENT diseases]. Zavgorodniaia EG Vestn Otorinolaringol; 2008; (3):74-6. PubMed ID: 18837165 [No Abstract] [Full Text] [Related]
10. [Anticancer chemotherapy in otorhinolaryngology (personal experience)]. Poch Viñals R An R Acad Nac Med (Madr); 1982; 99(2):197-230. PubMed ID: 7149214 [No Abstract] [Full Text] [Related]
11. [Antiblastic therapy in otorhinolaryngology]. Simoncelli C Valsalva; 1965 Jun; 41(3):253-7. PubMed ID: 5836083 [No Abstract] [Full Text] [Related]
12. [Local use of digitoxin in otorhinolaryngology and its borderline branches]. Birkholz HU Z Allgemeinmed; 1970 Jul; 46(20):1036-8. PubMed ID: 5512738 [No Abstract] [Full Text] [Related]
13. [Experiences with terramycin in ENT-therapy]. Weiss W Landarzt; 1964 Aug; 40(23):997-9. PubMed ID: 5827940 [No Abstract] [Full Text] [Related]
15. [Persistent infections in the children presenting with chronic ENT diseases: the potential of etiotropic therapy]. Levina AS; Babachenko IV; Vozhik AA; Kvetnaya AS Vestn Otorinolaringol; 2015; 80(5):46-50. PubMed ID: 26525472 [TBL] [Abstract][Full Text] [Related]
17. [Diseases of the lymphatic ring--10-year experience of a partnership practice for ENT diseases]. Maier M; Maier A Z Allgemeinmed; 1974 Sep; 50(26):1150-2. PubMed ID: 4409248 [No Abstract] [Full Text] [Related]
18. [Value of the association of formaldehyde and tyrothricin in a solution for local action in otorhinolaryngology]. Grimaud ; Jeannin C J Fr Otorhinolaryngol Chir Maxillofac; 1965; 14(5):549-52. PubMed ID: 5853553 [No Abstract] [Full Text] [Related]
19. [Glucocorticoids: ENT specialty provides broad indications spectrum for low-dose therapy]. Klimek L MMW Fortschr Med; 1999 Aug; 141(31-32):62-3. PubMed ID: 10766538 [No Abstract] [Full Text] [Related]
20. [Chronicles of St. Petersburg pharmacology (on 210th anniversary of the Department of Pharmacology of the St. Petersburg State Military Medical Academy)]. Shabanov PD Eksp Klin Farmakol; 2009; 72(4):46-51. PubMed ID: 19803371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]